Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cgh.2013.09.010 | DOI Listing |
Eur J Case Rep Intern Med
September 2024
Department of Gastroenterology, Faculty of Medicine, University of Balamand, El Koura, Lebanon.
Unlabelled: Dabigatran, a commonly prescribed anticoagulant medication, has been associated with esophagitis, referred to as dabigatran-induced esophagitis (DIE). We report a case of DIE occurring in a patient following left atrial ablation for atrial fibrillation. This case emphasizes the importance of recognizing the possible combined detrimental effects of left atrial ablation and dabigatran on the esophageal mucosa and highlights the clinical and endoscopic characteristics associated with DIE.
View Article and Find Full Text PDFDEN Open
April 2024
Department of Gastroenterology and Hepatology Graduate School of Biomedical Sciences, Nagasaki University Nagasaki Japan.
Dabigatran is a useful and widely used drug for stroke prevention in patients with atrial fibrillation. However, it has been reported to cause esophagitis. Herein, we report the case of a 77-year-old man with dabigatran-induced esophagitis with blue pigmentation, which is known to be a rare adverse effect.
View Article and Find Full Text PDFBMJ Case Rep
August 2021
Department of General Medicine, Chiba University Hospital, Chiba, Japan.
Eur J Hosp Pharm
March 2023
Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China
Objectives: Dabigatran-induced oesophagitis has emerged in recent years. However, the incidence and clinical characteristics of patients with dabigatran-induced oesophagitis have not yet been clarified. The aim of this study was to examine the clinical characteristics of the disease.
View Article and Find Full Text PDFChin Med J (Engl)
December 2020
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!